Shandong Boan Biotechnology Co., Ltd. (FRA:UJ9)

Germany flag Germany · Delayed Price · Currency is EUR
0.7850
-0.0700 (-8.19%)
At close: Feb 20, 2026
Market Cap513.69M -9.9%
Revenue (ttm)89.95M +5.1%
Net Income3.81M -48.2%
EPS0.01 -53.6%
Shares Outn/a
PE Ratio134.92
Forward PE29.98
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Average Volume132
Open0.7650
Previous Close0.8550
Day's Range0.7650 - 0.7850
52-Week Range0.7550 - 2.1200
Betan/a
RSI43.01
Earnings DateMar 26, 2026

About FRA:UJ9

Shandong Boan Biotechnology Co., Ltd., a biopharmaceutical company, develops, manufactures, and markets biologics in Mainland China. The company offers Boyounuo (BA1101), an anti-VEGF humanized monoclonal antibody injection for mCRC, advanced metastatic or recurrent non-small cell lung cancer, recurrent glioblastoma, epithelial ovarian, fallopian tube, primary peritoneal cancer, cervical cancer, and hepatocellular carcinoma indications; Boyoubei (BA6101), a human immunoglobulin G2 monoclonal antibody of the RANK ligand for the treatment of post... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2013
Employees 714
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol UJ9
Full Company Profile

Financial Performance

Financial numbers in CNY Financial Statements